A 62-year-old with type 2 diabetes and prior MI is on metformin and statin, eGFR 55. What glucose-lowering strategy adds CV benefit?...

Question

A 62-year-old with type 2 diabetes and prior MI is on metformin and statin, eGFR 55. What glucose-lowering strategy adds CV benefit?

Accepted Answer

Add SGLT2 inhibitor or GLP-1 receptor agonist with proven CV benefit

Answer

Add sulfonylurea

Answer

Add basal insulin

Answer

No change; glucose therapy has no CV effect

Answer

Thiazolidinedione

us-usmle-step-2 MCQ (SBA): Type 2 Diabetes with ASCVD